Quantification of circulating cell-free DNA to predict patient survival in non-small-cell lung cancer

We used computed tomography (CT) to explore the prognostic value of cell-free (cf) DNA quantification and its predictive efficacy over time after chemotherapy in non-small-cell lung cancer (NSCLC) patients. In total, 177 NSCLC patients were enrolled in a prospective biomarker trial. Consecutive pair...

Descripción completa

Detalles Bibliográficos
Autores principales: Hyun, Myung Han, Sung, Jae Sook, Kang, Eun Joo, Choi, Yoon Ji, Park, Kyong Hwa, Shin, Sang Won, Lee, Sung Yong, Kim, Yeul Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706884/
https://www.ncbi.nlm.nih.gov/pubmed/29212238
http://dx.doi.org/10.18632/oncotarget.21769

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706884/
https://www.ncbi.nlm.nih.gov/pubmed/29212238
http://dx.doi.org/10.18632/oncotarget.21769

Ejemplares similares